NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues were up 23 percent year over year on an adjusted basis.

The company's total revenues for the three months ended Sept. 30 were $101.3 million, compared with Q3 2017 revenues of $82.2 million adjusted for the change to ASC 606 accounting standards that the company adopted this January, and reported revenues of $83.8 million. Wall Street analysts had expected revenues of $94.4 million for the third quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.